Plain-English translation of NCT07493603 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing whether , a traditional Chinese herbal medicine, can safely help treat coronary heart disease—a condition where arteries to the heart become clogged with plaque—when combined with standard Western heart medications. Researchers want to see if taking this medication alongside your regular heart drugs improves symptoms and how your blood vessels heal. They will also study how this treatment might work at a deeper, cellular level to repair damaged blood vessels.
Many people with coronary heart disease still have chest pain and limited activity even while taking standard medications. This trial explores whether the medication might offer additional benefits beyond conventional treatments, especially for older adults who may benefit from approaches that target both the symptoms and the underlying blood vessel damage.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups for 12 weeks. One group takes standard heart medications only, while the other group takes the same standard medications plus the herbal medication as granules. You'll visit the research clinic multiple times for heart checkups, blood tests, ultrasounds, and heart scans. You'll also provide two small blood samples for research and report any side effects or changes in how you feel to the team. The study continues monitoring you on standard medication alone for an additional 24 weeks after the herbal treatment ends.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
China